HomeInsights52 Week High Stocks

Marksans Pharma Ltd 52 Week High

Marksans Pharma Ltd 52 Week High

stocks purchased

₹ 2.6 Cr

Volume Transacted

(Jan 8, 2025)

stocks purchased

92.8 K

Stocks Traded

(Jan 8, 2025)

Last Updated on: Jan 08, 2025

Image

Marksans Pharma Ltd

NSE: MARKSANS

YEARHIGH

₹ 358.5

Last updated on: Jan 08, 2025

Key Highlights

  • The 52 Week HIGH of Marksans Pharma Ltd is ₹ 358.5 as of 08 Jan 25 .

Company Fundamentals for Marksans Pharma Ltd

No data available

Market Price of Marksans Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Marksans Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
08 Jan 2025283.4
07 Jan 2025289.5
06 Jan 2025285.35
03 Jan 2025297.55
02 Jan 2025298
01 Jan 2025304.7
31 Dec 2024296.7
30 Dec 2024287.35
27 Dec 2024293.6
26 Dec 2024290.15

Asset Value vs Market Value of Marksans Pharma Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Marksans Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Marksans Pharma Ltd

No data available

* All values are in crore

Marksans Pharma Ltd News Hub

News

Marksans Pharma receives USFDA approval for Loratadine Tablets

Marksans Pharma announced the final approval of the Company's Abbreviated New Drug Applica...

Read more

22 Nov 2024 12:47

News

Marksans Pharma gains after receiving final nod for Loratadine Tablets from USFDA

The said drugs are indicated for the treatment of allergic rhinitis caused by pollen and u...

Read more

22 Nov 2024 13:23

News

Marksans Pharma gains after Q2 PAT rises 16% YoY to Rs 97 cr

The firm stated that growth was witnessed across all key markets, led by US and followed b...

Read more

12 Nov 2024 13:22

News

Marksans Pharma to declare Quarterly Result

Marksans Pharma will hold a meeting of the Board of Directors of the Company on 12 Novembe...

Read more

23 Oct 2024 17:41

News

Marksans Pharma announces receipt of UKMHRA approval for Fluoxetine capsules

Marksans Pharma'announced that its wholly owned subsidiary Relonchem has received Marketin...

Read more

21 Aug 2024 20:00

News

Marksans Pharma's Verna unit successfully completes USFDA inspection

Marksans Pharma announced that he USFDA has issued an Establishment Inspection Report (EIR...

Read more

20 Aug 2024 14:37

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week High of Marksans Pharma Ltd

What is the significance of Marksans Pharma Ltd reaching its 52-week high?

Marksans Pharma Ltd reaching its 52-week high indicates strong market confidence and a positive outlook on the company's financial health and growth prospects. This milestone often reflects successful business performance and can boost investor sentiment.

Why do investors monitor Marksans Pharma Ltd 52-week high?

Investors monitor Marksans Pharma Ltd 52-week high to gauge the stock's peak performance and overall market strength, which can indicate robust financial health and growth potential. It also helps them assess if the stock is trading near its maximum value, influencing decisions on buying, holding, or selling.

Is Marksans Pharma Ltd a good buy when it hits its 52-week high?

Whether Marksans Pharma Ltd is a good buy at its 52-week high depends on various factors, including the company's future growth prospects, overall market conditions, individual investment strategies, and other important Marksans Pharma Ltd fundamentals.

What should I consider before investing in Marksans Pharma Ltd at its 52-week high?

Before investing in Marksans Pharma Ltd at its 52-week high, consider evaluating the company's recent financial performance, growth potential, and overall market conditions to ensure it aligns with your investment goals. Additionally, assess whether the stock's current valuation justifies the potential for future returns and if it fits your risk tolerance.

Can Marksans Pharma Ltd stock price continue to rise after reaching its 52-week high?

Marksans Pharma Ltd stock price can continue to rise after reaching its 52-week high if it maintains strong fiscal performance and favorable market conditions. However, future growth depends on numerous factors such as company earnings, industry trends, and broader economic conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions